Free Trial

Biotricity Q3 2023 Earnings Report

Biotricity logo
$0.35 0.00 (-0.03%)
As of 03:55 PM Eastern

Biotricity EPS Results

Actual EPS
-$0.54
Consensus EPS
-$0.54
Beat/Miss
Met Expectations
One Year Ago EPS
N/A

Biotricity Revenue Results

Actual Revenue
$2.46 million
Expected Revenue
$2.80 million
Beat/Miss
Missed by -$340.00 thousand
YoY Revenue Growth
N/A

Biotricity Announcement Details

Quarter
Q3 2023
Time
Q3 2023 Earnings Release

Biotricity Earnings Headlines

2025: Crypto Opportunities You Can’t Afford to Miss
Cryptocurrencies are once again gaining incredible momentum, and savvy investors are positioning themselves to capitalize on this surge in 2025. The question is—will you be among them? With groundbreaking advancements and increasing institutional adoption on the horizon, there's never been a better time to explore the potential gains in crypto. What’s Fueling the Crypto Comeback?
Biotricity Inc BTCY
See More Biotricity Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Biotricity? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Biotricity and other key companies, straight to your email.

About Biotricity

Biotricity (OTCMKTS:BTCY), a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. The company is based in Redwood City, California.

View Biotricity Profile

More Earnings Resources from MarketBeat